References in periodicals archive ?
There are many treatments available for heart failure that are very effective at reducing symptoms and delaying the progression of the condition.
Abraham, MD, director of heart failure and cardiac transplantation at the University of Cincinnati College of Medicine and a member of the steering committee.
To test the theory that TNF plays a central role in congestive heart failure, Brett Giroir and Debora Bryant of the University of Texas Southwestern Medical Center in Dallas and their colleagues studied 30 mice that had been genetically engineered to make extra TNF in their heart tissues.
Between 2 to 3 million Americans have heart failure, and 400,000 new cases are diagnosed each year.
We were pleased to participate in this demonstration and are proud that our performance was rated the best in heart failure management.
Researchers found that key biomarkers of heart failure increased in animal hearts with induced heart damage, but decreased in animals whose damaged hearts were supported with the MYO-VAD.
Heart failure is particularly common in elderly patients and becomes dramatically more prevalent in the population as people reach the age of 65 and beyond.
In hospitals across the nation, treating fluid overload in heart failure patients is costly and outcomes often fall short of physician expectations and patient needs," said John Erb, CEO of CHF Solutions.
OTCBB: VASO), a leader in noninvasive management of cardiovascular diseases, announced today three presentations highlighting the benefits of EECP(R) therapy in patients with heart failure were made at the 10th Annual Heart Failure Society of America Scientific (HFSA) Meeting held in Seattle, Washington, September 10-13.
NEW YORK -- Daxor Corporation (AMEX:DXR), a medical instrumentation and biotechnology company, today announced significant results from blood volume data utilizing Daxor's BVA-100 was reported at the Heart Failure Society of America's (HFSA) Annual Scientific Meeting held last week in Seattle, WA.
NASDAQ:NTMD) announced today that five poster presentations highlighting new findings related to BiDil(R) (isosorbide dinitrate/hydralazine hydrochloride) will be presented at the 10th Annual Meeting of the Heart Failure Society of America (HFSA), being held at the Washington State Convention & Trade Center in Seattle, from September 10 - 13th.

Full browser ?